BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25364051)

  • 1. Estimating the cost to U.S. health departments to conduct HIV surveillance.
    Shrestha RK; Sansom SL; Laffoon BT; Farnham PG; Shouse RL; MacMaster K; Hall HI
    Public Health Rep; 2014; 129(6):496-504. PubMed ID: 25364051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of methods for estimating the cost of human immunodeficiency virus-testing interventions.
    Shrestha RK; Sansom SL; Farnham PG
    J Public Health Manag Pract; 2012; 18(3):259-67. PubMed ID: 22473119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of work-related asthma in selected U.S. states using surveillance guidelines for state health departments--California, Massachusetts, Michigan, and New Jersey, 1993-1995.
    Jajosky RA; Harrison R; Reinisch F; Flattery J; Chan J; Tumpowsky C; Davis L; Reilly MJ; Rosenman KD; Kalinowski D; Stanbury M; Schill DP; Wood J
    MMWR CDC Surveill Summ; 1999 Jun; 48(3):1-20. PubMed ID: 10421216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The costs and effectiveness of surveillance of communicable disease: a case study of HIV and AIDS in England and Wales.
    Morris S; Gray A; Noone A; Wiseman M; Jathanna S
    J Public Health Med; 1996 Dec; 18(4):415-22. PubMed ID: 9023800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and economies of scale in the accelerated program for prevention of mother-to-child transmission of HIV in Zimbabwe.
    Ochoa-Moreno I; Bautista-Arredondo S; McCoy SI; Buzdugan R; Mangenah C; Padian NS; Cowan FM
    PLoS One; 2020; 15(5):e0231527. PubMed ID: 32433715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rising population cost for treating people living with HIV in the UK, 1997-2013.
    Mandalia S; Mandalia R; Lo G; Chadborn T; Sharott P; Youle M; Anderson J; Baily G; Brettle R; Fisher M; Gompels M; Kinghorn G; Johnson M; McCarron B; Pozniak A; Tang A; Walsh J; White D; Williams I; Gazzard B; Beck EJ;
    PLoS One; 2010 Dec; 5(12):e15677. PubMed ID: 21209893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing Data to Care-What Are the Costs for the Health Department?
    Neblett Fanfair R; Shrestha RK; Randall L; Lucas C; Nichols L; Camp NM; Brady K; Jenkins H; Altice F; Villanueva M; DeMaria A
    J Acquir Immune Defic Syndr; 2019 Sep; 82 Suppl 1():S57-S61. PubMed ID: 31425397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
    Suraratdecha C; Stuart RM; Edwards M; Moore R; Liu N; Wilson DP; Albalak R
    PLoS One; 2020; 15(10):e0238499. PubMed ID: 33119591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct cost associated with the development and implementation of a local syndromic surveillance system.
    Kirkwood A; Guenther E; Fleischauer AT; Gunn J; Hutwagner L; Barry MA
    J Public Health Manag Pract; 2007; 13(2):194-9. PubMed ID: 17299325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Affordable Care Act and the Burden of High Cost Sharing and Utilization Management Restrictions on Access to HIV Medications for People Living with HIV/AIDS.
    Zamani-Hank Y
    Popul Health Manag; 2016 Aug; 19(4):272-8. PubMed ID: 26565514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-stage sampling method for clinical surveillance of individuals in care for HIV infection in the United States.
    Sullivan PS; Karon JM; Malitz FE; Broyles S; Mokotoff ED; Buskin SE; Fleming PL
    Public Health Rep; 2005; 120(3):230-9. PubMed ID: 16134562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1999 Dec; 48(RR-13):1-27, 29-31. PubMed ID: 10632297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences.
    Hutchinson AB; Farnham PG; Dean HD; Ekwueme DU; del Rio C; Kamimoto L; Kellerman SE
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):451-7. PubMed ID: 16980906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Economic Cost of Communicable Disease Surveillance in Local Public Health Agencies.
    Atherly A; Whittington M; VanRaemdonck L; Lampe S
    Health Serv Res; 2017 Dec; 52 Suppl 2(Suppl 2):2343-2356. PubMed ID: 29130264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assays for estimating HIV incidence: updated global market assessment and estimated economic value.
    Morrison CS; Homan R; Mack N; Seepolmuang P; Averill M; Taylor J; Osborn J; Dailey P; Parkin N; Ongarello S; Mastro TD
    J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29165892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.